CD31 Antibody Market size was valued at USD 1.2 Billion in 2024 and is projected to reach USD 2.5 Billion by 2033, exhibiting a CAGR of 9.5% from 2026 to 2033.
The global CD31 Antibody Market size was valued at approximately USD 1.3 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 6.2% from 2023 to 2030. This market growth can be attributed to the rising prevalence of cardiovascular diseases, increasing research in oncology, and advancements in immunoassays. North America dominated the CD31 Antibody Market in 2022, accounting for the largest revenue share, with an estimated value of USD 500 million. This is due to the growing demand for diagnostic tools and therapeutic applications in the region, along with the presence of advanced healthcare infrastructure. Europe held the second largest market share in 2022, valued at approximately USD 350 million, driven by the increasing adoption of targeted therapies and clinical research in the region. The Asia Pacific region is projected to witness the fastest growth during the forecast period, with a CAGR of 7.4%. The market in Asia Pacific was valued at USD 250 million in 2022 and is expected to grow significantly due to the expanding healthcare infrastructure, rising awareness about healthcare, and growing investments in biotechnology. Latin America and the Middle East & Africa are also anticipated to experience moderate growth in the CD31 Antibody Market, owing to the improving healthcare facilities and rising research activities. Opportunities in these regions lie in the increasing applications of CD31 antibodies in cancer immunotherapy, diagnostics, and regenerative medicine, which is expected to further propel market expansion in the coming years.
Get | Download Sample Copy with TOC, Graphs & List of Figures @ http://verifiedmarketreports.com/download-sample/?rid=738430&utm_source=Pulse_G_April&utm_medium=226
BosterBio
Bio-Rad
Bioss
Thermo Fisher Scientific
NSJ Bioreagents
R and D Systems
Abcam
BioLegend
GeneTex
Novus Biologicals
SouthernBiotech
LifeSpan BioSciences
Enzo Life Sciences
Bethyl Laboratories
Abbexa
ProSci
Proteintech
Synaptic Systems
BIOCARE MEDICAL
CUSABIO Technology
Absolute Antibody
EpiGentek
Biorbyt
Wuhan Fine Biotech
Sino Biological
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase Of This Report @ https://www.verifiedmarketreports.com/ask-for-discount/?rid=738430&utm_source=Pulse_G_April&utm_medium=226
Growing demand for below applications around the world has had a direct impact on the growth of the Global CD31 Antibody Market
Monoclonal Antibodies
Polyclonal Antibodies
Recombinant Antibodies
Chimeric Antibodies
Basic Research
Translational Research
Academic Research Institutes
Pharmaceutical and Biotechnology Companies
Diagnostic Laboratories
CROs (Contract Research Organizations)
Direct Sales
Online Sales
Third-party Distributors
Liquid Formulations
Lyophilized Powders
Ready-to-use Kits
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ https://www.verifiedmarketreports.com/product/cd31-antibody-market/
1. Introduction of the Global CD31 Antibody Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global CD31 Antibody Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global CD31 Antibody Market, By Type
6. Global CD31 Antibody Market, By Application
7. Global CD31 Antibody Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. Global CD31 Antibody Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/